Literature DB >> 31504080

Suppression of Blue Light at Night Ameliorates Metabolic Abnormalities by Controlling Circadian Rhythms.

Norihiro Nagai1, Masahiko Ayaki1, Tatsuo Yanagawa2,3, Atsuhiko Hattori4, Kazuno Negishi1, Takuro Mori5, Takahiro J Nakamura5,6, Kazuo Tsubota1.   

Abstract

Purpose: Light-emitting diodes that emit high-intensity blue light are associated with blue-light hazard. Here, we report that blue light disturbs circadian rhythms by interfering with the clock gene in the suprachiasmatic nucleus (SCN) and that suppression of blue light at night ameliorates metabolic abnormalities by controlling circadian rhythms.
Methods: C57BL/6J mice were exposed to 10-lux light for 30 minutes at Zeitgeber time 14 for light pulse with blue light or blue-light cut light to induce phase shift of circadian rhythms. Phase shift, clock gene expression in SCN, and metabolic parameters were analyzed. In the clinical study, healthy participants wore blue-light shield eyewear for 2 to 3 hours before bed. Anthropometric data analyses, laboratory tests, and sleep quality questionnaires were performed before and after the study.
Results: In mice, phase shift induced with a blue-light cut light pulse was significantly shorter than that induced with a white light pulse. The phase of Per2 expression in the SCN was also delayed after a white light pulse. Moreover, blood glucose levels 48 hours after the white light pulse were higher than those after the blue-cut light pulse. Irs2 expression in the liver was decreased with white light but significantly recovered with the blue-cut light pulse. In a clinical study, after 1 month of wearing blue-light shield eyeglasses, there were improvements in fasting plasma glucose levels, insulin resistance, and sleep quality. Conclusions: Our results suggest that suppression of blue light at night effectively maintains circadian rhythms and metabolism.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31504080     DOI: 10.1167/iovs.19-27195

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Light at Night Exposure Effects on Differentiation and Cell Cycle in the Rat Liver With Autonomic Nervous System Denervation.

Authors:  Mohammad Hossein Heidari; Mona Zamanian Azodi; Mohammad Reza Zali; Zahra Akbari
Journal:  J Lasers Med Sci       Date:  2019-12-01

2.  Effects of morning and evening exposures to blue light of varying illuminance on ocular growth rates and ocular rhythms in chicks.

Authors:  Debora L Nickla; Frances Rucker; Christopher P Taylor; Shanta Sarfare; William Chen; Jonathan Elin-Calcador; Xia Wang
Journal:  Exp Eye Res       Date:  2022-01-29       Impact factor: 3.467

3.  Effect of Constant Illumination on the Function of the Hypothalamic-Pituitary-Adrenal Axis in Nonhuman Primates.

Authors:  N D Goncharova; O A Chigarova; T E Oganyan
Journal:  Bull Exp Biol Med       Date:  2021-10-28       Impact factor: 0.804

Review 4.  Light at Night and Disrupted Circadian Rhythms Alter Physiology and Behavior.

Authors:  Jacob R Bumgarner; Randy J Nelson
Journal:  Integr Comp Biol       Date:  2021-10-04       Impact factor: 3.392

5.  The light-curing unit: An essential piece of dental equipment.

Authors:  Richard B Price; Jack L Ferracane; Reinhard Hickel; Braden Sullivan
Journal:  Int Dent J       Date:  2020-07-21       Impact factor: 2.607

Review 6.  Interconnections between circadian clocks and metabolism.

Authors:  Dongyin Guan; Mitchell A Lazar
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

7.  Metabolic Effects of Light at Night are Time- and Wavelength-Dependent in Rats.

Authors:  Anayanci Masís-Vargas; Wayne I G R Ritsema; Jorge Mendoza; Andries Kalsbeek
Journal:  Obesity (Silver Spring)       Date:  2020-07       Impact factor: 5.002

Review 8.  Metabolic Implications of Exposure to Light at Night: Lessons from Animal and Human Studies.

Authors:  Giulia Fleury; Anayanci Masís-Vargas; Andries Kalsbeek
Journal:  Obesity (Silver Spring)       Date:  2020-07       Impact factor: 5.002

9.  Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel.

Authors:  Nan Zheng; Fengying Yin; Qinglin Yu; Jinyan Zhong; Jin Yang; Zhifeng Xu; Jia Su; Xiaomin Chen
Journal:  J Clin Lab Anal       Date:  2021-01-26       Impact factor: 2.352

10.  Pregabalin abuse and dependence during insomnia and protocol for short-term withdrawal management with diazepam: examples from case reports.

Authors:  Basavaraja Papanna; Carlo Lazzari; Kapil Kulkarni; Sivasankar Perumal; Abdul Nusair
Journal:  Sleep Sci       Date:  2021 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.